Back
NovoCure Vs. Sage Therapeutics Industry Stock Comparison
Sell
35
NVCR
NovoCure
Last Price:
12.23
Seasonality Move:
12.01%
Sell
25
SAGE
Sage Therapeutics
Last Price:
13.60
Seasonality Move:
10.04%
Sell
35
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.23. The Score for NVCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $13.58. The Score for SAGE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $13.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 38.18 | Sell |
Chaikin Money Flow: | 432127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.35 - 14.63) | Sell |
Bollinger Bands (100): | (12.91 - 15.45) | Sell |
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.7 | Sell |
Relative Strength Index (14 RSI): | 31.87 | Sell |
Chaikin Money Flow: | -1372135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.97 - 18.39) | Sell |
Bollinger Bands (100): | (17.53 - 24.89) | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.14 | Buy |
20-day SMA: | 13.46 | Sell |
50-day SMA: | 14.49 | Sell |
200-day SMA: | 17.81 | Sell |
8-day EMA: | 12.38 | Sell |
20-day EMA: | 13.08 | Sell |
50-day EMA: | 13.89 | Sell |
200-day EMA: | 22.73 | Sell |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.5 | Buy |
20-day SMA: | 15.45 | Sell |
50-day SMA: | 18.93 | Sell |
200-day SMA: | 22.41 | Sell |
8-day EMA: | 13.84 | Sell |
20-day EMA: | 15.33 | Sell |
50-day EMA: | 18.02 | Sell |
200-day EMA: | 24.19 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.08 per share, and an increase next year of $1.34 per share.
NovoCure Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sage Therapeutics Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |